Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01AHL
|
|||
Former ID |
DNC006771
|
|||
Drug Name |
7-hydroxy-1,2,9,9a-tetrahydrofluoren-3-one
|
|||
Synonyms |
CHEMBL377622; 7-hydroxy-1,2,9,9a-tetrahydrofluoren-3-one
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C13H12O2
|
|||
Canonical SMILES |
C1CC(=O)C=C2C1CC3=C2C=CC(=C3)O
|
|||
InChI |
1S/C13H12O2/c14-10-3-4-12-9(6-10)5-8-1-2-11(15)7-13(8)12/h3-4,6-8,14H,1-2,5H2
|
|||
InChIKey |
TVWXDDLDMKKZJT-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Estrogen receptor beta (ESR2) | Target Info | Inhibitor | [1] |
KEGG Pathway | Estrogen signaling pathway | |||
Prolactin signaling pathway | ||||
Pathway Interaction Database | Plasma membrane estrogen receptor signaling | |||
Validated nuclear estrogen receptor beta network | ||||
Validated nuclear estrogen receptor alpha network | ||||
Reactome | Nuclear Receptor transcription pathway | |||
WikiPathways | SIDS Susceptibility Pathways | |||
Ovarian Infertility Genes | ||||
Integrated Pancreatic Cancer Pathway | ||||
Nuclear Receptors |
References | Top | |||
---|---|---|---|---|
REF 1 | The discovery of tetrahydrofluorenones as a new class of estrogen receptor beta-subtype selective ligands. Bioorg Med Chem Lett. 2006 Jul 1;16(13):3489-94. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.